IP Library Granted Patent US 8,969,034
Granted Patent B2
US 8,969,034 · App. 12/988,344 · Granted Mar 3, 2015

Endoglycosidases that cleave

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,969,034
App. No.
12/988,344
Granted
Mar 3, 2015
Kind
B2
Abstract

Methods and compositions have been described that relate to a newly identified polypeptide family wherein each member has O-glycosidase activity and specified sequence characteristics. This family of enzymes can be used for example for cleaving O-linked glycans and for synthesis of neoglycopeptides or neoglycoproteins.

Claims (16)

1. A preparation in a reaction vessel, comprising a recombinant polypeptide and glycerol, the recombinant polypeptide comprising amino acids 1-1155 of SEQ ID NO: 4, wherein the recombinant polypeptide consists of less than 1400 amino acids, and lacks a carbohydrate-binding domain at the C-terminal end.

2. A synthetic vector comprising a nucleic acid that encodes a polypeptide according to claim 1 .

3. A method, comprising:

a) combining in a reaction vessel a eukaryotic glycoprotein or glycopeptide with a purified prokaryotic glycosidase having an amino acid sequence comprising:

i) an amino acid sequence at least 35.2% identical to SEQ ID NO: 2;

ii) SEQ ID NO: 1; and

iii) an FDY amino acid sequence in a central conserved domain wherein the number of amino acids between the FDY and a C-terminal end of the polypeptide is no more than 200 amino acids,

wherein the glycosidase polypeptide consists of less than 1400 amino acids and lacks a carbohydrate-binding domain at the C-terminal end;

b) cleaving a Core 3 (GIcNAcβ1,3GaINAc) O-linked glycan in the glycoprotein or glycopeptide; and

c) separating the glycan products cleaved from the glycoprotein or glycopeptide.

4. The method according to claim 3 , further comprising treating the glycoprotein or glycopeptide with a neuraminidase.

5. The method according to claim 4 , further comprising sequentially or simultaneously treating the glycoprotein or glycopeptide with the neuraminidase and the glycosidase.

6. The method according to claim 3 , wherein the glycosidase is active at 25° C.

7. The method according to claim 3 , wherein the glycosidase is capable of cleaving 100% of the Core 3 O-linked glycans as determined by thin layer chromatography (TLC).

8. The method according to claim 3 , further comprising cleaving the Core 3 O-linked glycans at pH 2.0 to 9.0.

9. The preparation according to claim 1 further comprising neuraminidase.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2010
From: KOUTSIOULIS, DIMITRIS; GUTHRIE, ELLEN
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 025226/0343 →